Skip to content
Riskpilot
← Back to search
Sign in
Get full access
NoseOption AB
AB
Active
Org 5568612294
Surbrunnsgatan 42, 113 48
Stockholm
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2011 · 14 years old
7 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
NoseOption AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
AM
Adrian Mikael Zacharias Liljefors
Chief Executive Officer
Chief Executive Officer
2022
SD
Samuel Douglas Bjälkemo
Audit
Audit
2022
Former (2)
PB
Pål Bruu
Chief Executive Officer
Chief Executive Officer
2021 – 2022
IM
Ingrid Maria Frisell Svedin
Audit
Audit
2022 – 2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
DJ
Dan Josefsberg
Board of Directors
Board of Directors
2020
Former (12)
BJ
Bo Jörgen Malmberg
Board of Directors
Board of Directors
2022 – 2023
TH
Tomas Hultman
Board of Directors
Board of Directors
2020 – 2022
BF
Birgitta Fernström Gunneflo
Board of Directors
Board of Directors
2020 – 2022
JS
Jens Sixten Pettersson
Deputy Board Member
Deputy Board Member
2022 – 2023
DR
Daniel Rubin Taub
Deputy Board Member
Deputy Board Member
2022 – 2023
JP
Johan Peter Prom
Board of Directors
Board of Directors
2022 – 2023
AW
Alexander Walter Myers
Chairman
Chairman
2020 – 2021
SM
Sven Mats Einar Dörring
Board of Directors
Board of Directors
2022 – 2023
JE
Jan Erik Oscar Ingdahl
Board of Directors
Board of Directors
2022 – 2023
MB
Mats Björn Rosén
Board of Directors
Board of Directors
2022 – 2023
TL
Tomas Ludvigsson
Board of Directors
Board of Directors
2022 – 2023
DM
Dan-Luis Mangell
Board of Directors
Board of Directors
2022 – 2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Nosa Plugs AB (publ)
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on NoseOption AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network